Probes for and nucleic acid encoding the muscular dystrophy protein, dystrophin
AssigneeChildren's Medical Center Corporation
InventorsLouis M. Kunkel, Anthony Monaco, Eric P. Hoffman, Michel Koenig
Life of this patent
Estimating the term…
Abstract
The invention relates to a muscular dystrophy (MD) probe comprising a substantially purified single-stranded nucleic acid sequence capable of hybridizing to a region of DNA on a human X chromosome between the deletion break point at Xp21.3 and the translocation break point at X;11. The invention also relates to a 14 kb cDNA corresponding to the complete MD gene and probes produced therefrom useful in genetic methods of diagnosis of MD. Furthermore, the invention relates to the polypeptide, dystrophin, which corresponds to the MD gene product, and antibodies thereto that are useful in a variety of methods for immunodiagnosis of MD.
Claims6
A substantially pure, single-stranded nucleic acid which selectively hybridizes to a region of DNA on a human X chromosome between the deletion break point at Xp21.3 and the translocation break point at X;11, under conditions that are sufficiently stringent to prevent hybridization to other sequences.
A substantially pure nucleic acid probe selected from the group consisting of the probes deposited with the ATCC under the twelve accession numbers 57666 to 57677, inclusive.
A substantially pure nucleic acid encoding a polypeptide that has the amino acid sequence of FIG. 8.
A substantially pure, single-stranded nucleic acid fragment which selectively hybridizes to a nucleic acid encoding a polypeptide that has the amino acid sequence of FIG. 8, under conditions that are sufficiently stringent to prevent hybridization to other sequences.
A substantially pure nucleic acid encoding dystrophin, the nucleic acid having the sequence shown in FIG. 5.
Dependencies are inferred from the claim text.